10 commercial payer policies list J9326. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
10 policies from 8 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9326 |
|---|---|---|
| Telisotuzumab vedotin-tllv (Emrelis) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Telisotuzumab vedotin-tllv (Emrelis) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J9326 |
|---|---|---|
| Telisotuzumab vedotin-tllv (Emrelis) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Telisotuzumab vedotin-tllv (Emrelis) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9326 |
|---|---|---|
| Telisotuzumab vedotin-tllv (e.g., Emrelis) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9326 |
|---|---|---|
| Telisotuzumab vedotin-tllv (Emrelis) | Aug 30, 2025 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9326 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9326 |
|---|---|---|
| Telisotuzumab Vedotin-tllv (Emrelis); CP.PHAR.733 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9326 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9326 |
|---|---|---|
| Emrelis (telisotuzumab vedotin-tllv) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |